These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 15355933)
1. RANTES (CCL5) induces a CCR5-dependent accelerated shedding of syndecan-1 (CD138) and syndecan-4 from HeLa cells and forms complexes with the shed ectodomains of these proteoglycans as well as with those of CD44. Charnaux N; Brule S; Chaigneau T; Saffar L; Sutton A; Hamon M; Prost C; Lievre N; Vita C; Gattegno L Glycobiology; 2005 Feb; 15(2):119-30. PubMed ID: 15355933 [TBL] [Abstract][Full Text] [Related]
2. Binding of the CC-chemokine RANTES to syndecan-1 and syndecan-4 expressed on HeLa cells. Slimani H; Charnaux N; Mbemba E; Saffar L; Vassy R; Vita C; Gattegno L Glycobiology; 2003 Sep; 13(9):623-34. PubMed ID: 12773479 [TBL] [Abstract][Full Text] [Related]
3. The shedding of syndecan-4 and syndecan-1 from HeLa cells and human primary macrophages is accelerated by SDF-1/CXCL12 and mediated by the matrix metalloproteinase-9. Brule S; Charnaux N; Sutton A; Ledoux D; Chaigneau T; Saffar L; Gattegno L Glycobiology; 2006 Jun; 16(6):488-501. PubMed ID: 16513763 [TBL] [Abstract][Full Text] [Related]
4. Syndecan-4 is a signaling molecule for stromal cell-derived factor-1 (SDF-1)/ CXCL12. Charnaux N; Brule S; Hamon M; Chaigneau T; Saffar L; Prost C; Lievre N; Gattegno L FEBS J; 2005 Apr; 272(8):1937-51. PubMed ID: 15819887 [TBL] [Abstract][Full Text] [Related]
5. A syndecan-4/CXCR4 complex expressed on human primary lymphocytes and macrophages and HeLa cell line binds the CXC chemokine stromal cell-derived factor-1 (SDF-1). Hamon M; Mbemba E; Charnaux N; Slimani H; Brule S; Saffar L; Vassy R; Prost C; Lievre N; Starzec A; Gattegno L Glycobiology; 2004 Apr; 14(4):311-23. PubMed ID: 15033938 [TBL] [Abstract][Full Text] [Related]
7. Interaction of RANTES with syndecan-1 and syndecan-4 expressed by human primary macrophages. Slimani H; Charnaux N; Mbemba E; Saffar L; Vassy R; Vita C; Gattegno L Biochim Biophys Acta; 2003 Oct; 1617(1-2):80-8. PubMed ID: 14637022 [TBL] [Abstract][Full Text] [Related]
8. Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase. Fitzgerald ML; Wang Z; Park PW; Murphy G; Bernfield M J Cell Biol; 2000 Feb; 148(4):811-24. PubMed ID: 10684261 [TBL] [Abstract][Full Text] [Related]
9. Role of CCL5 in invasion, proliferation and proportion of CD44+/CD24- phenotype of MCF-7 cells and correlation of CCL5 and CCR5 expression with breast cancer progression. Zhang Y; Yao F; Yao X; Yi C; Tan C; Wei L; Sun S Oncol Rep; 2009 Apr; 21(4):1113-21. PubMed ID: 19288016 [TBL] [Abstract][Full Text] [Related]
10. Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and growth factor receptor activation. Subramanian SV; Fitzgerald ML; Bernfield M J Biol Chem; 1997 Jun; 272(23):14713-20. PubMed ID: 9169435 [TBL] [Abstract][Full Text] [Related]
11. Synergistic effect of tumor necrosis factor-alpha and interferon-gamma on enterocyte shedding of syndecan-1 and associated decreases in internalization of Listeria monocytogenes and Staphylococcus aureus. Henry-Stanley MJ; Zhang B; Erlandsen SL; Wells CL Cytokine; 2006 Jun; 34(5-6):252-9. PubMed ID: 16884912 [TBL] [Abstract][Full Text] [Related]
12. RANTES (CCL5) uses the proteoglycan CD44 as an auxiliary receptor to mediate cellular activation signals and HIV-1 enhancement. Roscic-Mrkic B; Fischer M; Leemann C; Manrique A; Gordon CJ; Moore JP; Proudfoot AE; Trkola A Blood; 2003 Aug; 102(4):1169-77. PubMed ID: 12714503 [TBL] [Abstract][Full Text] [Related]
13. Growth factor-induced shedding of syndecan-1 confers glypican-1 dependence on mitogenic responses of cancer cells. Ding K; Lopez-Burks M; Sánchez-Duran JA; Korc M; Lander AD J Cell Biol; 2005 Nov; 171(4):729-38. PubMed ID: 16286510 [TBL] [Abstract][Full Text] [Related]
14. Syndecan-1 and syndecan-4 are involved in RANTES/CCL5-induced migration and invasion of human hepatoma cells. Charni F; Friand V; Haddad O; Hlawaty H; Martin L; Vassy R; Oudar O; Gattegno L; Charnaux N; Sutton A Biochim Biophys Acta; 2009 Oct; 1790(10):1314-26. PubMed ID: 19632304 [TBL] [Abstract][Full Text] [Related]
15. Exploitation of syndecan-1 shedding by Pseudomonas aeruginosa enhances virulence. Park PW; Pier GB; Hinkes MT; Bernfield M Nature; 2001 May; 411(6833):98-102. PubMed ID: 11333985 [TBL] [Abstract][Full Text] [Related]
16. Insulin promotes shedding of syndecan ectodomains from 3T3-L1 adipocytes: a proposed mechanism for stabilization of extracellular lipoprotein lipase. Reizes O; Goldberger O; Smith AC; Xu Z; Bernfield M; Bickel PE Biochemistry; 2006 May; 45(18):5703-11. PubMed ID: 16669614 [TBL] [Abstract][Full Text] [Related]
17. Multiple pathways of amino terminal processing produce two truncated variants of RANTES/CCL5. Lim JK; Burns JM; Lu W; DeVico AL J Leukoc Biol; 2005 Aug; 78(2):442-52. PubMed ID: 15923218 [TBL] [Abstract][Full Text] [Related]
18. Binding of HCV E2 to CD81 induces RANTES secretion and internalization of CC chemokine receptor 5. Nattermann J; Nischalke HD; Feldmann G; Ahlenstiel G; Sauerbruch T; Spengler U J Viral Hepat; 2004 Nov; 11(6):519-26. PubMed ID: 15500552 [TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase-dependent shedding of syndecan-3, a transmembrane heparan sulfate proteoglycan, in Schwann cells. Asundi VK; Erdman R; Stahl RC; Carey DJ J Neurosci Res; 2003 Sep; 73(5):593-602. PubMed ID: 12929127 [TBL] [Abstract][Full Text] [Related]
20. Expression of CCL5 (RANTES) and CCR5 in prostate cancer. Vaday GG; Peehl DM; Kadam PA; Lawrence DM Prostate; 2006 Feb; 66(2):124-34. PubMed ID: 16161154 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]